Increasing local control and sur - vival after definite chemoradiation seems possible not only by using optimized radiation fractionation schedules and escalated total doses , but also by associating more convenient and less toxic chemotherapy agents at the right cytotoxic or radio - sensitizing dose 明确的放化疗后无论是选用优化放疗加大总剂量，还是在细胞毒素或敏感放疗剂量中加用方便并且毒性小的化疗药物，似乎都能提高局部控制和生存期。
Conclusions in patients 75 years of age or younger who have myocardiak infarction with st - segment ekevation and who receive aspirin and a standard fibrinokytic regimen ? the addition of ckopidogrek improves the patency rate of the infarct - rekated artery and reduces ischemic compkications 结论在年龄75岁、患有st段抬高心肌梗死并接受阿司匹林和标准纤溶方案治疗的病人中，加用氯吡格雷治疗可改善梗死相关动脉的通畅率，并减少缺血性并发症。
In patients with mild persistent asthma , we evaluated the efficacy of intermittent short - course corticosteroid treatment guided by a symptom - based action plan alone or in addition to daily treatment with either inhaled budesonide or oral zafirlukast over a one - year period 我们在轻度持续性哮喘病人中，评估了下列2种疗法治疗1年的疗效：仅在症状导向用药计划的指导下行间断短疗程皮质类固醇治疗；或在每天吸入布地奈德或口服扎鲁司特基础上加用上述治疗。
Anyhow ， we ' ll hae to use different classes in most of our patients ， and then to decide if we start with a ? blocker and then we add a diuretic or start with a diuretic and then add a ? blockers ， i think it ' s not so releant ， so for the clinician ， it is not such an important question 无论如何，对于大多数患者我们都会用到不同类别的药物，所以是应该先用?受体阻滞剂再加用利尿剂还是先用利尿剂再加用?受体阻滞剂这个问题我认为是无关紧要的，对于临床医生而言这并不是一个很重要的问题。
Methods 156 subjects were randomized into two groups : treatment group in which 79 cases were treated by aerosol inhalation of " chuan ke zhi " plus routine therapy and control group in which 77 cases were treated by pulmicort respules plus routine therapy , with a course of one week 方法选择急性喘息性支气管炎及哮喘急性发作的患儿156例，随机分为治疗组（ 79例，在常规抗感染止咳的基础上使用喘可治加可必特氧气驱动雾化吸入）和对照组（ 77例，在常规治疗的基础上加用普米克令舒及可必特氧气驱动雾化吸入） ，两组其他治疗相同，疗程均为1周。
Patients in the control group were treated with comprehensive therapy including symptomatic supportive treatment , antiinfective therapy and artificial liver plasmapheresis etc . , while those in the treated group were orally taken szrd additionally . patients condition of sleeping and changes of total bilirubin prothrombin activity , tumor necrosis factor and interleukin1 il1 were observed before and after treatment , and the adverse reactions were observed as well 对照组采用对症支持抗感染人工肝血浆置换等综合治疗，治疗组在此治疗基础上，加用酸枣仁汤口服治疗2周，观察两组患者睡眠情况，检测治疗前后血清总胆红素tbil凝血酶原活动度pta肿瘤坏死因子tnf和白细胞介素1 il1等指标，并观察药物的不良反应。
Methods : thirty - five patients with cognitive dysfunction secondary to acute cerebral infarction were treated with tongxingluo ; thirey - five patients without tongxingluo treatment were involved as control group , both groups were given routine therapy , cognitive function examinations were performed before and 4 weeks after treatment 方法：对35例伴有认知功能障碍的急性脑梗死患者在常规药物治疗的基础上加用通心络胶囊治疗，同时选用35例急性脑梗死患者采用常规药物治疗作为对照组，两组患者在治疗前和治疗4周后均进行认知功能测验。
Anyhow ， we ' ll have to use different classes in most of our patients ， and then to decide if we start with a ? blocker and then we add a diuretic or start with a diuretic and then add a ? blockers ， i think it ' s not so relevant ， so for the clinician ， it is not such an important question 无论如何，对于大多数患者我们都会用到不同类别的药物，所以是应该先用?受体阻滞剂再加用利尿剂还是先用利尿剂再加用?受体阻滞剂这个问题我认为是无关紧要的，对于临床医生而言这并不是一个很重要的问题。
